Mass General research is helping children and adults with neurofibromatosis lead a full life.
The FDA recently sponsored a milestone meeting aimed at pursuing alternative treatments for celiac patients who do not respond well to a gluten-free diet.
When the late Paul Poth was diagnosed with a form of cancer so rare there was no treatment, he helped to launch a highly promising area of cancer research that is giving new hope to patients.
Running to train for a marathon cuts heart disease risk and boosts heart structure and function, according to a study led by cardiologist Aaron Baggish, MD.
Mass General researcher and donor Joel Habener, MD, advances diabetes research and the careers of promising young investigators.
The scientists at the Massachusetts Alzheimer’s Disease Research Center are pioneering a unique new gene therapy that could stop the disease in its tracks.
A team from the MGH Center for Assessment Technology and Continuous Health (CATCH) has launched an iPhone app created to help study type 2 diabetes.
The Making Tracks for Celiacs Walk/Runs have raised more than $2.5 million for celiac disease research and national and local awareness initiatives.
When it comes to food, the physician-researcher is passionate about an ingredient that has fueled both his career and a national dietary fervor: gluten.
At its 2015 seminar, the MGH Psychiatry Leadership Council celebrated achieving its membership goal and raising more than $28 million to support MGH Psychiatry since 2007.